134029-83-7Relevant academic research and scientific papers
Potent inhibitory effects of resveratrol derivatives on progression of prostate cancer cells
Yoo, Kyung Mi,Kim, Sanghee,Moon, Bo Kyung,Kim, Sung Soo,Kim, Kyung Tack,Kim, Sun Yeou,Choi, Sang Yoon
, p. 238 - 241 (2006)
Resveratrol has been identified as a potent anticancer agent in a variety of studies. In this study, several resveratrol derivatives were synthesized and investigated in the search for an anticancer agent with higher efficacy than resveratrol. During our
Synthesis of heterocycle-based analogs of resveratrol and their antitumor and vasorelaxing properties
Bertini, Simone,Calderone, Vincenzo,Carboni, Isabella,Maffei, Roberta,Martelli, Alma,Martinelli, Adriano,Minutolo, Filippo,Rajabi, Mehdi,Testai, Lara,Tuccinardi, Tiziano,Ghidoni, Riccardo,MacChia, Marco
experimental part, p. 6715 - 6724 (2010/10/19)
New resveratrol (RES) analogs were developed by replacing the aromatic 'core' of our initial naphthalene-based RES analogs with pseudo-heterocyclic (salicylaldoxime) or heterocyclic (benzofuran, quinoline, and benzothiazole) scaffolds. The resulting analo
Synthesis and Evaluation of Stilbene and Dihydrostilbene Derivatives as Potential Anticancer Agents That Inhibit Tubulin Polymerization
Cushman, Mark,Nagarathnam, Dhanapalan,Gopal, D.,Chakraborti, Asit K.,Lin, Chii M.,Hamel, Ernest
, p. 2579 - 2588 (2007/10/02)
An array of cis-, trans-, and dihydrostilbenes and some N-arylbenzylamines were synthesized and evaluated for their cytotoxicity in the five cancer cell cultures A-549 lung carcinoma, MCF-7 breast carcinoma, HT-29 colon adenocarcinoma, SKMEL-5 melanoma, a
